Novel galenic formulations for delivering immunochemotherapies: kill intelligently, remove the checkpoint and let the T cells in!

Oliver Kepp; Guido Kroemer

doi:10.1080/2162402X.2020.1846358

Novel galenic formulations for delivering immunochemotherapies: kill intelligently, remove the checkpoint and let the T cells in!

Oliver Kepp, Guido Kroemer

Résultats de recherche: Contribution à un journal › Editorial

langue originale	Anglais
Numéro d'article	1846358
journal	OncoImmunology
Volume	9
Numéro de publication	1
Les DOIs	https://doi.org/10.1080/2162402X.2020.1846358
état	Publié - 1 janv. 2020

Accès au document

10.1080/2162402X.2020.1846358

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{1aa45307ae7d4507b237d043bd925b0e,

title = "Novel galenic formulations for delivering immunochemotherapies: kill intelligently, remove the checkpoint and let the T cells in!",

author = "Oliver Kepp and Guido Kroemer",

note = "Funding Information: OK receives funding from the DIM Elicit; GK is supported by the Ligue contre le Cancer ({\'e}quipe labellis{\'e}e); Agence National de la Recherche (ANR)–Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; AMMICa US23/CNRS UMS3655; Association pour la recherche sur le cancer (ARC); Association “Ruban Rose”; Canc{\'e}rop{\^o}le Ile-de-France; Chancelerie des universit{\'e}s de Paris (Legs Poix), Fondation pour la Recherche M{\'e}dicale (FRM); a donation by Elior; European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR); Gustave Roussy Odyssea, the European Union Horizon 2020 Project Oncobiome; Fondation Carrefour; High-end Foreign Expert Program in China [GDW20171100085], Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; LeDucq Foundation; the LabEx Immuno-Oncology [ANR-18-IDEX-0001]; the RHU Torino Lumi{\`e}re; the Seerave Foundation; the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); and the SIRIC Cancer Research and Personalized Medicine (CARPEM).",

year = "2020",

month = jan,

day = "1",

doi = "10.1080/2162402X.2020.1846358",

language = "English",

volume = "9",

journal = "OncoImmunology",

issn = "2162-4011",

number = "1",

}

TY - JOUR

T1 - Novel galenic formulations for delivering immunochemotherapies

T2 - kill intelligently, remove the checkpoint and let the T cells in!

AU - Kepp, Oliver

AU - Kroemer, Guido

N1 - Funding Information: OK receives funding from the DIM Elicit; GK is supported by the Ligue contre le Cancer (équipe labellisée); Agence National de la Recherche (ANR)–Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; AMMICa US23/CNRS UMS3655; Association pour la recherche sur le cancer (ARC); Association “Ruban Rose”; Cancéropôle Ile-de-France; Chancelerie des universités de Paris (Legs Poix), Fondation pour la Recherche Médicale (FRM); a donation by Elior; European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR); Gustave Roussy Odyssea, the European Union Horizon 2020 Project Oncobiome; Fondation Carrefour; High-end Foreign Expert Program in China [GDW20171100085], Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; LeDucq Foundation; the LabEx Immuno-Oncology [ANR-18-IDEX-0001]; the RHU Torino Lumière; the Seerave Foundation; the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); and the SIRIC Cancer Research and Personalized Medicine (CARPEM).

PY - 2020/1/1

Y1 - 2020/1/1

UR - http://www.scopus.com/inward/record.url?scp=85096084819&partnerID=8YFLogxK

U2 - 10.1080/2162402X.2020.1846358

DO - 10.1080/2162402X.2020.1846358

M3 - Editorial

C2 - 33244441

AN - SCOPUS:85096084819

SN - 2162-4011

VL - 9

JO - OncoImmunology

JF - OncoImmunology

IS - 1

M1 - 1846358

ER -